FDA Adds Warning to mRNA Vaccine Fact Sheets

News
Article

Reports of myocarditis and pericarditis following Pfizer-BioNTech and Moderna vaccinations prompts warnings.

FDA announced on June 25, 2021, the addition of warnings about myocarditis and pericarditis to the fact sheets for healthcare providers administering messenger RNA-based vaccines from Moderna and Pfizer-BioNTech; fact sheets for patients also were revised to provide information about potential reactions and when to seek medical attention.

The Centers for Disease Control and Prevention (CDC) reported on June 23, 2021, that more than 1000 cases of myocarditis and pericarditis in patients receiving the mRNA vaccine had been reported to the Vaccine Adverse Event Reporting System. The cases primarily involved male adolescents and young adults after receiving a second dose of the vaccine. CDC calls the reports to be rare and patients typically recover quickly. More than 300 million doses of mRNA vaccines have been administered.

The vaccine fact sheet revisions were implemented following review of data presented at a meeting of CDC’s Advisory Committee on Immunization Practices. FDA said the agency and CDC will continue to monitor reports, gather information, and assess longer-term outcomes.

Source: FDA

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes